Home

emp BIOTECH News

December 17th, 2023

emp BIOTECH GmbH Opens Compliance Hotline.
At emp Biotech GmbH, we prioritize transparency, integrity, and accountability.
More

We value the well-being of our employees, customers, and stakeholders. When you have a concern about any potential breach of regulation or internal policies within our organization, we encourage you to use our whistleblowing channel.
Click here to access our whistleblowing channel and take an active role in promoting transparency and accountability.

December 6th, 2023

Meet emp BIOTECH‘s Franziska Meier-Hättig at the Antibody Therapeutic Xchange, Zurich, December 6th. Linkedin

13th to 15th November

emp BIOTECH Delegation Attending Medica 2023.
Are you attending this year’s Medica in Düsseldorf?
More

Take this opportunity to meet with delegates from emp Biotech. Three delegates from emp Biotech will be attending Medica between Monday 13th to Wednesday 15th November. Present from emp BIOTECH will be:
Derek Levison, Managing Director
Alistair Hurst, Business Development Manager
Franziska Meier-Hättig, Product Manager
Contact us if you wish to meet with the emp BIOTECH team during Medica.


All news

Exhibitions and conferences

Feb 03, 2024SLAS 2024Boston
Mar 11, 2024BPI WestSan Diego
Mar 19, 2024TIDES AsiaKyoto
May 07, 2024CPHI North AmericaPhiladelphia
May 14, 2024TIDES USABoston
May 28, 2024PREP 2024Philadelphia
Oct 21, 2024BPI AsiaKyoto

Learn more about emp BIOTECH
and the work we do

We are a primary manufacturer of fine chemicals, labeling kits, cell culture transfection agents and solid phases for purification – ranging from early-stage R&D to large-scale manufacturing in pharmaceutical and biotech environments.

emp BIOTECH Blog

March 22, 2023Optimizing Use of Your Desalting Column
Desalting columns are an essential tool in the field of molecular biology, biochemistry, and protein research. They facilitate the removal of unwanted salts, small molecules, and other contaminants from a sample, purifying and concentrating target molecules in the process.
more